PASSAGE BIO INC. - COMMON STOCK

Passage Bio Presents Preclinical and Interim Clinical Data for PBFT02 in FTD-GRN at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual Conference

24 10 2024 06:00:00 提供 Nasdaq GlobeNewswire

Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines Conference

23 9 2024 06:00:00 提供 Nasdaq GlobeNewswire

Passage Bio to Present Positive Interim Data from Cohort 1 Patients with FTD-GRN in upliFT-D Study at 14th International Conference on Frontotemporal Dementias (ISFTD2024)

16 9 2024 06:00:00 提供 Nasdaq GlobeNewswire

Passage Bio Welcomes Tom Kassberg to Board of Directors

10 9 2024 06:52:00 提供 Nasdaq GlobeNewswire

Passage Bio to Present at H.C. Wainwright 26th Annual Global Investment Conference

30 8 2024 06:00:00 提供 Nasdaq GlobeNewswire

Passage Bio Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights

08 8 2024 06:00:00 提供 Nasdaq GlobeNewswire

Passage Bio to Participate in Upcoming Investor Conferences

06 8 2024 06:00:00 提供 Nasdaq GlobeNewswire

Passage Bio Out-licenses Three Pediatric Gene Therapy Programs to GEMMA Biotherapeutics and Enters New Research Collaboration

01 8 2024 06:00:00 提供 Nasdaq GlobeNewswire

Passage Bio Announces Positive Feedback from FDA on Expansion of upliFT-D Trial of PBFT02 to Include FTD-C9orf72 Patients

16 7 2024 06:00:00 提供 Nasdaq GlobeNewswire

Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference

05 6 2024 06:30:00 提供 Nasdaq GlobeNewswire

Passage Bio Announces Recipient of Third Annual Tachi Yamada Scholarship Award

21 5 2024 07:00:00 提供 Nasdaq GlobeNewswire

Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights

14 5 2024 06:00:01 提供 Nasdaq GlobeNewswire

Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

22 4 2024 06:00:00 提供 Nasdaq GlobeNewswire

Passage Bio Seeks Pennsylvania College Student Candidates for Third Annual Tachi Yamada Scholarship Program

05 3 2024 06:00:00 提供 Nasdaq GlobeNewswire

Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights

04 3 2024 06:00:17 提供 Nasdaq GlobeNewswire

Passage Bio to Participate in Upcoming Investor Conferences

27 2 2024 06:00:26 提供 Nasdaq GlobeNewswire

Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

31 1 2024 06:30:00 提供 Nasdaq GlobeNewswire

Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities

20 12 2023 06:00:00 提供 Nasdaq GlobeNewswire

Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

17 11 2023 15:30:00 提供 Nasdaq GlobeNewswire

Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights

13 11 2023 06:00:00 提供 Nasdaq GlobeNewswire